Management of valvular disease in pregnancy: a global perspective (Q27025877)

M. R. Johnson

series ordinal

2

1 reference

P. Zilla

series ordinal

3

1 reference

J. W. Roos-Hesselink

series ordinal

4

1 reference

language of work or name

1 reference

7 May 2015

1 reference

published in

European Heart Journal

1 reference

volume

36

1 reference

issue

18

1 reference

page(s)

1078-89

1 reference

Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Prospective multicenter study of pregnancy outcomes in women with heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Pregnancy in women with heart disease in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

The global burden of group A streptococcal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Prevalence of rheumatic heart disease detected by echocardiographic screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

The effect of valvular heart disease on maternal and fetal outcome of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Cardiac operations during pregnancy: review of factors influencing fetal outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

The spectrum of severe rheumatic mitral valve disease in a developing country. Correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Long-term outcomes after surgery for rheumatic mitral valve disease: valve repair versus mechanical valve replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Cardiac surgery capacity in sub-saharan Africa: quo vadis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Valvular heart disease and pregnancy: part II: prosthetic valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Long-term survival and valve-related complications in young women with cardiac valve replacements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Improved long-term survival for rheumatic mitral valve repair compared to replacement in the young

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Modern cardiac valve devices--bioprostheses and mechanical prostheses: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Prosthetic heart valves: catering for the few.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Under-use of the Ross operation--a lost opportunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Pregnancy outcomes in women with aortic valve substitutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Does pregnancy influence the durability of human aortic valve substitutes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Guidelines on the management of valvular heart disease (version 2012).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Small hook thread (Quill) and soft felt internal splint to increase the primary repair strength of lacerated rabbit Achilles tendons: biomechanical analysis and considerations for hand surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Pregnancy in women with prosthetic heart valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Risk of warfarin during pregnancy with mechanical valve prostheses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Risks of anticoagulant therapy in pregnant women with artificial heart valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Use of low molecular weight heparin in pregnant women with mechanical heart valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Mechanical aortic valve replacement in young women planning on pregnancy: maternal and fetal outcomes under low oral anticoagulation, a pilot observational study on a comprehensive pre-operative counseling protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Pregnancy with prosthetic heart valves - 30 years' nationwide experience in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Card

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Haemodynamic effects of oxytocin in women with severe preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the Eu

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Risk factors associated with cardiac surgery during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050

Peripartum cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV050